Insulin resistance, diabetes, and atherosclerosis: Thiazolidinediones as therapeutic interventions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11886-002-0116-3.pdf
Reference120 articles.
1. Parulkar AA, Pendergrass ML, Granda-Ayala R, et al.: Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med 2001, 134:61–71. The nonhypoglycemic effects of TZDs have become a major area of interest. This review provides an excellent overview of both in vivo and in vitro evidence for such TZD action, which include decreases in cardiovascular risk among patients with the insulinresistance syndrome.
2. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595–1607.
3. Deedwania PC: The deadly quartet revisited. Am J Med 1998, 105:1S-3S.
4. Owen P, Evans M: Therapy and clinical trials: type 2 diabetes: lifestyle and beyond. Curr Opin Lipidol 2002, 13:351–353.
5. Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [published erratum appears in N Engl J Med 1997, 337:356]. N Engl J Med 1997, 336:973–979.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vegetarian Diet and Cardiometabolic Risk among Asian Indians in the United States;Journal of Diabetes Research;2018
2. Activation of PPAR-γ reduces HPA axis activity in diabetic rats by up-regulating PI3K expression;Experimental and Molecular Pathology;2016-10
3. PPARGin Human Adipogenesis: Differential Contribution of Canonical Transcripts and Dominant Negative Isoforms;PPAR Research;2014
4. Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!;Current Cardiology Reviews;2012-06-01
5. Rosiglitazone Causes Endothelial Dysfunction in Humans;Journal of Cardiovascular Pharmacology and Therapeutics;2011-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3